First published January 2, 2007 - More info
Unequivocal direct observations have established that the bacteria that cause device-related and other chronic infections grow in matrix-enclosed biofilms. The diagnostic and therapeutic strategies that have served us so well in the partial eradication of acute epidemic bacterial diseases have not yielded accurate data or favorable outcomes when applied to these biofilm diseases. We discuss the potential benefits of the application of the new methods and concepts developed by biofilm science and engineering to the clinical management of infectious diseases.
William Costerton, Richard Veeh, Mark Shirtliff, Mark Pasmore, Christopher Post, Garth Ehrlich
Original citation: J. Clin. Invest.112:1466-1477 (2003). doi:10.1172/JCI200320365
Citation for this corrigendum: J. Clin. Invest.117:278 (2007). doi:10.1172/JCI20365C1
The reference citation for Figure 1A was incorrect. The correct citation appears in the statement below.
Image published with permission from the American Society for Microbiology (60).
The authors regret this error.